Clinical trial
Iodine I 131 in Treating Patients With Thyroid Cancer
NCT00416949 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Terminated
Key facts
| NCT number | NCT00416949 |
|---|---|
| Title | Iodine I 131 in Treating Patients With Thyroid Cancer |
| Official title | Dose-Response in Radionuclide Therapy of Thyroid Cancer |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Device |
| Interventions | Patient-specific dosimetry |
| Enrollment | 9 |
| Start date | Apr 1, 2006 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Dec 28, 2006 |
| Last update posted | Jul 18, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: